retatrutide for diabetes type 2 Retatrutide: The New Triple-Agonist Weight Loss Treatment Retatrutide Injection: Package Insert /

Medication: GLP-1 drugs need to be taken for life to maintain results

The new oral formulation delivers weight loss results comparable to its injectable counterpart in clinical studies

The company uses NABP-certified pharmacies to fill prescriptions, though it does not publicly disclose which specific pharmacies it partners with

Gastrointestinal issues, such as diarrhea, nausea and constipation, are perhaps the most widely reported side effects (research has found that these impact up to 60% of users)

Understanding these variables helps set appropriate expectations and supports a more personalised approach to treatment

Ozempic, known generically as semaglutide, is a GLP-1 receptor agonist that supports blood sugar regulation by stimulating insulin secretion, reducing glucagon release, and slowing gastric emptying